ARTICLE | Clinical News
OncoGel regulatory update
March 21, 2011 7:00 AM UTC
The European Commission granted Orphan Drug designation for BTG's OncoGel to treat esophageal cancer. OncoGel is paclitaxel formulated using the ReGel polymeric drug delivery system. The product has O...